BIOQUAL, Inc.
BIOQUAL, Inc.
9600 Medical Center Dr.
Rockville, MD 20850
301 251 2801
800 208 3149

Financials/Press Releases

Investor Relations
BIOQUAL, Inc. is a public company traded on the Pink Sheets - Symbol BIOQ.

BIOQUAL, Inc.'s transfer agent is:
Registrar and Transfer Company
10 Commerce Drive
Cranford, New Jersey 07016
(800) 368-5948

Contact
Michael O'Flaherty
Chief Operating Officer
Corporate Secretary
BIOQUAL, Inc. 9600 Medical Center Drive
Rockville, MD 20850-3336
Phone: (301) 251-2801
Fax: (301) 251-1260


Financial Reports and Press Releases

BIOQUAL, Inc., announces completion of the purchase of ABL's In-Vivo Animal Model Services Related Assets by BIOQUAL and entry into Strategic Teaming Agreement.[Updated 02/27/14]

 

BIOQUAL Presents Financial Results for FY 2014 Second Quarter Ending November 30, 2013 [Updated 02/19/14]

 

Mark Lewis Letter To Shareholders [01/13/14]

 

BIOQUAL Presents Financial Results for FY 2014 First Quarter Ending August 31, 2013 [Updated 01/02/14]

 

Management’s Discussion and Analysis Related to the Audited Financial Statements for Fiscal Year 2013 [Updated 01/02/14]

 

BIOQUAL, Inc. and ABL, Inc., Announce Agreement for the Sale of ABL's In-Vivo Animal Model Services Related Assets to BIOQUAL and Strategic Teaming Agreement

[Updated 12/09/13]

 

BIOQUAL, Inc. and Subsidiary Presents Audited Consolidated Financial Statements and Supplementary Information for Fiscal Year 2013 and 2012 [Updated 10/28/13]

 

Press Release, 10/28/13, BIOQUAL, Inc. and Subsidiary Presents Financial Results for Fiscal Year 2013

 

BIOQUAL Presents Financial Results for FY 2013 Third Quarter Ending February 28, 2013 [Updated 07/01/13]

 

Press Release, Management Change Effective June 01, 2013

[Updated 06/05/13]

 

John Landon Letter To Shareholders [12/19/12]

Contact
Mark Lewis, Ph.D.
President/CEO
BIOQUAL, Inc.
9600 Medical Center Drive
Rockville, MD 20850-3336
Phone: (301) 251-2801, ext. 112
Fax: (301) 251-1260